Verano Holdings (VRNO) Goodwill & Intangibles (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Goodwill & Intangibles of $725.6 million for Q1 2026, down 24.8% year-over-year from $964.9 million in Q1 2025, and down 1.96% quarter-over-quarter from $740.1 million in Q4 2025.
Verano Holdings (VRNO) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Goodwill & Intangibles for 6 consecutive years, with $725.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 24.8% year-over-year to $725.6 million; the TTM figure through Mar 2026 stood at $725.6 million (down 24.8% YoY), while the FY2025 annual figure was $740.1 million, down 24.5% from the prior year.
- Goodwill & Intangibles fell to $725.6 million in Q1 2026 per VRNO's latest filing, from $740.1 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $1.7 billion in Q2 2022 and bottomed at $725.6 million in Q1 2026.
- Historically, Goodwill & Intangibles has averaged $1.2 billion across 5 years, with a median of $1.3 billion in 2024.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles jumped 489.05% — and 2025, when it declined 28.34%.
- Verano Holdings' Goodwill & Intangibles stood at $1.4 billion in 2022, then retreated by 9.13% to $1.3 billion in 2023, then declined by 25.6% to $980.2 million in 2024, then decreased by 24.5% to $740.1 million in 2025, then slipped by 1.96% to $725.6 million in 2026.
- Business Quant data shows VRNO's Goodwill & Intangibles at $725.6 million in Q1 2026, $740.1 million in Q4 2025, and $931.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Verano Holdings | 438.82 Mn | 353.62 Mn | 99.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 711.13 Mn |
| Mar 31, 2026 | 725.58 Mn |
| Dec 31, 2025 | 740.10 Mn |
| Sep 30, 2025 | 931.37 Mn |
| Jun 30, 2025 | 948.12 Mn |
| Mar 31, 2025 | 964.86 Mn |
| Dec 31, 2024 | 980.24 Mn |
| Sep 30, 2024 | 1.30 Bn |
| Jun 30, 2024 | 1.27 Bn |
| Mar 31, 2024 | 1.29 Bn |
| Dec 31, 2023 | 1.32 Bn |
| Sep 30, 2023 | 1.38 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.43 Bn |
| Dec 31, 2022 | 1.45 Bn |
| Sep 30, 2022 | 1.71 Bn |
| Jun 30, 2022 | 1.72 Bn |
| Dec 31, 2021 | 1.75 Bn |
| Sep 30, 2021 | 289.79 Mn |
| Jun 30, 2021 | 380.46 Mn |